QUEBEC CITY, June 9, 2011 /CNW/ - Advitech Inc. ("Advitech" or the
"Corporation") (TSXV: AVI) announces that it has granted today a total
of 638,500 stock options to an officer.
Each stock option allows the holder thereof to acquire one common share
of Advitech until June 9, 2016 for a price of $0.10 per share. The
options are governed by the stock option plan of the Company and will
vest in three instalments on the first, second and third anniversary of
their date of grant.
Advitech, which includes its subsidiary Botaneco Specialty Ingredients
Inc. since November 20, 2009, is a health sciences and technology
company developing, manufacturing and marketing proprietary natural
ingredients and formulations for oral and topical applications that
have been clinically proven to be safe and effective for improving skin
health and well being. The Corporation's products are based on three
technological platforms which are: i) a superior multi-functional
emulsification delivery system derived from plant seed oleosomes for
formulation application in the topical cosmetic, OTC, Rx and natural
personal care specialty ingredient markets, ii) XP-828L for immune
mediated inflammatory disorders, and iii) IM for anti-aging and wound
healing. Advitech produces Hydresia®, a natural plant derived specialty ingredient which offers immediate
moisturization advantages, formulating cost savings and excellent
product aesthetics in a variety of product applications, Dermylex® for
the treatment of mild-to-moderate psoriasis, and NudremylTM which acts on skin reconstruction, cellular regeneration and skin
structure. More information is available and can be accessed at www.advitech.com and www.botaneco.ca.
This press release contains forward-looking statements, which reflect
the Corporation's current expectations regarding future events. The
forward-looking statements involve risks and uncertainties. Actual
results could differ materially from those projected herein.
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE Advitech Inc.
For further information:
Michael Stangel, President and CEO